Author/Authors :
Cansu، Dondu Uskudar نويسنده Division of Rheumatology, Department of Internal Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey , , Temel ، Tuncer نويسنده Department of Gastroenterology, Medical Faculty, Eskisehir
Osmangazi University, Eskisehir, Turkey , , Erturk، Adem نويسنده Division of Rheumatology, Department of Internal Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey , , Kasifoglu، Timucin نويسنده Division of Rheumatology, Department of Internal Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey , , Acu، Berat نويسنده Department of Radiology, Eskisehir Osmangazi University, Eskisehir, Turkey , , Korkmaz، Cengiz نويسنده Division of Rheumatology, Department of Internal Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey ,
Abstract :
Budd-Chiari syndrome, which is a rare complication of Behcet’s disease, carries a high mortality rate. The aim of the study was to present our long-term follow up experience with patients suffering from Budd-Chiari syndrome due to Behcet’s disease. The records of 402 patients with Behcet’s disease were evaluated retrospectively. To facilitate detection of the long-term complications caused by Budd-Chiari syndrome, the patients were evaluated via physical examinations, laboratory tests, imaging modalities, and endoscopy results. The data for 402 patients diagnosed with Behcet’s disease, who were followed up at our hospital over 16 years, were analyzed retrospectively. Five of these 402 patients (1.2%) were diagnosed as having Budd-Chiari syndrome. The patients with Budd-Chiari syndrome were aged between 23 and 54, and all five were male. The interval between the onset of Behcet’s disease and the development of Budd-Chiari syndrome ranged from 1 to 8 years. All the patients had combined venous occlusion (affecting the hepatic vein and inferior vena cava). Portal venous thrombosis was detected in only one patient (Case 1), who died 1 month after the diagnosis of Budd-Chiari syndrome. The survival time for the other four patients after the diagnosis of Budd-Chiari syndrome ranged from 4 to 16 years. During the long-term follow-up, hepatic masses were detected via radiological surveillance in Case 3 (in the form of large regenerative nodules) and Case 4 (nodular regenerative hyperplasia and cirrhosis). In our study, portal venous thrombosis was detected in the patient who died during the acute period only. A study including large numbers of Budd-Chiari-syndrome patients with Behcet’s disease and portal venous thrombosis would be helpful to determine the prognostic significance of portal venous thrombosis in Budd-Chiari-syndrome patients with Behcet’s disease. In addition, patients should be monitored regularly for the development of hepatic masses via a long-term surveillance program.
